XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 27, 2020   32,545          
Beginning balance at Dec. 27, 2020 $ (266,939) $ 453 $ 254,103 $ (14,168) $ 219,158 $ (741,724) $ 15,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [1] 67,373       66,137   1,236
Other comprehensive (loss) income, net of tax 3,933     3,933      
Repurchase and conversion of Series B Convertible Preferred Stock (in shares)   3,489          
Repurchase and conversion of Series B Convertible Preferred Stock 63,883 $ 35 174,631   (110,783)    
Cash dividends on common stock (14,844)   62   (14,906)    
Cash dividends on preferred stock (4,121)       (4,121)    
Exercise of stock options (in shares)   148          
Exercise of stock options 8,100 $ 1 8,099        
Acquisition of Company common stock (in shares)   (83)          
Acquisition of Company common stock (8,188)         (8,188)  
Stock-based compensation expense 8,202   8,202        
Issuance of restricted stock (in shares)   109          
Issuance of restricted stock 0   (5,665)     5,665  
Tax payments for equity award issuances (3,887)   (3,887)        
Distributions to noncontrolling interests (1,185)           (1,185)
Other (in shares)   7          
Other (225)   63   (716) 428  
Ending balance (in shares) at Jun. 27, 2021   36,215          
Ending balance at Jun. 27, 2021 (147,898) $ 489 435,608 (10,235) 154,769 (743,819) 15,290
Beginning balance (in shares) at Mar. 28, 2021   32,681          
Beginning balance at Mar. 28, 2021 (240,100) $ 453 251,285 (11,971) 242,119 (737,268) 15,282
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [1] 32,877       32,254   623
Other comprehensive (loss) income, net of tax 1,736     1,736      
Repurchase and conversion of Series B Convertible Preferred Stock (in shares)   3,489          
Repurchase and conversion of Series B Convertible Preferred Stock 63,883 $ 35 174,631   (110,783)    
Cash dividends on common stock (7,440)   31   (7,471)    
Cash dividends on preferred stock (709)       (709)    
Exercise of stock options (in shares)   107          
Exercise of stock options 5,802 $ 1 5,801        
Acquisition of Company common stock (in shares)   (68)          
Acquisition of Company common stock (6,921)         (6,921)  
Stock-based compensation expense 4,089   4,089        
Issuance of restricted stock (in shares)   5          
Issuance of restricted stock 0   (294)     294  
Tax payments for equity award issuances (52)   (52)        
Distributions to noncontrolling interests (615)           (615)
Other (in shares)   1          
Other (448)   117   (641) 76  
Ending balance (in shares) at Jun. 27, 2021   36,215          
Ending balance at Jun. 27, 2021 $ (147,898) $ 489 435,608 (10,235) 154,769 (743,819) 15,290
Beginning balance (in shares) at Dec. 26, 2021 35,800 35,797          
Beginning balance at Dec. 26, 2021 $ (172,458) $ 490 445,126 (9,971) 183,157 (806,472) 15,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 36,629       35,927   702
Other comprehensive (loss) income, net of tax (1,063)     (1,063)      
Cash dividends on common stock (25,101)   95   (25,196)    
Exercise of stock options (in shares)   39          
Exercise of stock options 1,908   1,908        
Acquisition of Company common stock (in shares)   (753)          
Acquisition of Company common stock (75,471)         (75,471)  
Stock-based compensation expense 9,101 $ 1 9,100        
Issuance of restricted stock (in shares)   229          
Issuance of restricted stock 0   (6,450)     6,450  
Tax payments for equity award issuances (in shares)   (70)          
Tax payments for equity award issuances (7,527)   (7,527)        
Distributions to noncontrolling interests (150)           (150)
Other (in shares)   6          
Other $ 334   3 0 46 288  
Ending balance (in shares) at Jun. 26, 2022 35,200 35,248          
Ending balance at Jun. 26, 2022 $ (233,798) $ 491 442,255 (11,034) 193,934 (875,205) 15,761
Beginning balance (in shares) at Mar. 27, 2022   35,675          
Beginning balance at Mar. 27, 2022 (208,444) $ 491 436,225 (9,316) 181,124 (832,603) 15,635
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 25,712       25,433   279
Other comprehensive (loss) income, net of tax (1,718)     (1,718)      
Cash dividends on common stock (12,493)   48   (12,541)    
Exercise of stock options (in shares)   22          
Exercise of stock options 1,167   1,167        
Acquisition of Company common stock (in shares)   (452)          
Acquisition of Company common stock (42,762)         (42,762)  
Stock-based compensation expense 4,925   4,925        
Issuance of restricted stock (in shares)   2          
Issuance of restricted stock 0   (81)     81  
Tax payments for equity award issuances (in shares)   (1)          
Tax payments for equity award issuances (65)   (65)        
Distributions to noncontrolling interests (150)           (150)
Other (in shares)   2          
Other $ 30   36 0 (82) 79 (3)
Ending balance (in shares) at Jun. 26, 2022 35,200 35,248          
Ending balance at Jun. 26, 2022 $ (233,798) $ 491 $ 442,255 $ (11,034) $ 193,934 $ (875,205) $ 15,761
[1] Net income to the Company for the three and six months ended June 27, 2021 excludes $713 and $1,500 allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[2] Net income to the Company for the three and six months ended June 26, 2022 excludes income of $18 and $528 allocable to the redeemable noncontrolling interests for our joint venture arrangements.